Humacyte
(NASDAQ:HUMAW)
$1.04
-0.94[-47.47%]
At close: May 16
$1.04
0[0.00%]
PreMarket: 8:24AM EDT

Humacyte Stock (NASDAQ:HUMAW), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Analyst Ratings for Humacyte

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Humacyte (HUMAW)?

A

There is no price target for Humacyte.

Q

What is the most recent analyst rating for Humacyte (HUMAW)?

A

There is no analyst for Humacyte.

Q

When was the last upgrade for Humacyte (HUMAW)?

A

There is no last upgrade for Humacyte.

Q

When was the last downgrade for Humacyte (HUMAW)?

A

There is no last downgrade for Humacyte.

Q

When is the next analyst rating going to be posted or updated for Humacyte (HUMAW)?

A

There is no next analyst rating for Humacyte.

Q

Is the Analyst Rating Humacyte (HUMAW) correct?

A

There is no next analyst rating for Humacyte.

Browse analyst ratings and price targets on all stocks.

People Also Watch